Influx Healthtech Limited IPO Review
Neutral91-91 · SME
✦
Analyst Verdict
Influx Healthtech Limited IPO
Neutral
IPO at a Glance
Price Band
91-91
Issue Size
58cr
Opens
2025-06-16
Closes
2025-06-18
Listing
2025-06-23
Category
SME
Key Strengths
✓Diversified portfolio across nutraceuticals, Ayurveda, and wellness products reduces sector-specific risks.
✓Rigorous QA/QC processes, global certifications (ISO, FDA), and adherence to food safety standards ensure consistent high product quality.
✓Formulation team develops safe, stable, and custom nutraceutical, cosmetic, and veterinary products for clients.
Key Risks
⚠High reliance on the nutraceutical industry makes the company vulnerable to demand shifts or disruptions in that sector.
⚠Geographic concentration in Palghar, Maharashtra exposes the company to regional operational risks.
⚠Dependence on a few key customers (top 10 contributing ~47–50% of revenue) poses a risk, loss of any could significantly impact revenue and profitability.
⚠High dependence on top 10 suppliers (36–39%) without long-term contracts may disrupt operations if key relationships weaken or prices rise.
⚠Discrepancies and non-compliances in corporate records may lead to regulatory penalties, affecting the Company’s financial position.
Frequently Asked Questions
Should I apply for Influx Healthtech Limited IPO?
Based on our analysis, our rating for Influx Healthtech Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Influx Healthtech Limited IPO?
High reliance on the nutraceutical industry makes the company vulnerable to demand shifts or disruptions in that sector. Geographic concentration in Palghar, Maharashtra exposes the company to regional operational risks. Dependence on a few key customers (top 10 contributing ~47–50% of revenue) poses a risk, loss of any could significantly impact revenue and profitability.
What are the strengths of Influx Healthtech Limited IPO?
Diversified portfolio across nutraceuticals, Ayurveda, and wellness products reduces sector-specific risks. Rigorous QA/QC processes, global certifications (ISO, FDA), and adherence to food safety standards ensure consistent high product quality. Formulation team develops safe, stable, and custom nutraceutical, cosmetic, and veterinary products for clients.
What is the price band of Influx Healthtech Limited IPO?
The price band for Influx Healthtech Limited IPO is 91-91. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more